Verdad Advisers »

Axsome Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 6.0k 169.02

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Axsome Therapeutics

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
FMR
T. Rowe Price Associates
Invesco
Geode Capital Management
Wellington Management Company
Deep Track Capital
State Street Corporation
Nomura Asset Management International
Adage Capital Partners GP
Alethea Capital Management
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Axsome Therapeutics